Notices issued to companies for introducing drugs without prior nod from NPPA: Government
The drugs include those used for treating conditions like diabetes, inflammation and chronic hepatitis C, among others
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Wockhardt
US FDA observations for Shendra facility not critical: Wockhardt
According to the company, half of the issues will be resolved in next fortnight The nine observations received by Wockhardt for…
Wockhardt receives QIDP status from US FDA
WCK 5222 is a new class of antibiotic for gram negative terrain for complicated urinary tract infections and HABP/ VABP Wockhardt…
Wockhardt’s Chikalthana plant gets GMP certificate from UKMHRA
The UK regulator had in October 2013 withdrawn the GMP certificate to the Chikalthana plant Wockhardt's Chikalthana plant at…
Wockhardt gets exemption from price control for three insulin products
The three products have been classified as new drugs and thus qualify for non-application of the DPCO 2013 Drug price regulator…
Wockhardt posts consolidated revenue of Rs 1231 crore in quarter ended Sept 30, 2015
EBIDTA was at Rs 201 crore
Sun Pharma, Wockhardt recall drugs from US market
Sun Pharma’s recall was initiated last month under Class-III classification while Wockhardt's recall was under class-II…
Wockhardt’s consolidated revenue for Q1FY16 grows by 15 per cent at Rs1141 crore
EBIDTA is up by 165 per cent at Rs 167 crore Wockhardt has posted its first quarter results for financial year 2016. The…
Wockhardt Q4FY15 net sales posted at Rs1079 crore
International business contributed 72 per cent of the total revenues during the FY14-15
Wockhardt recalls 12 drugs in US made at two India units
Wockhardt has decided to voluntarily recall all the remaining batches of 12-15 products that were manufactured in the Chikalthana…